PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH CARBONIC ANHYDRASE INHIBITORS

Pharmacoeconomic study of treatment primary open-angle glaucoma with carbonic anhydrise inhibitors by mean of costefficacy and budget impact analysis. Results have shown, that Azopt has benefits compare with Dorzopt and Trusopt from cost-efficacy perspective and can be claimed dominant. Futhermore A...

Full description

Bibliographic Details
Main Authors:	A. Yu. Kulikov, V. G. Serpik
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2015-03-01
Series:	Фармакоэкономика
Subjects:	primary open-angle glaucoma pharmacoeconomic studies cost-efficacy analysis budget impact analysis dorzolamide brinzolamid
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/21

Similar Items

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH FIX COMBINATION OF CARBONIC ANHYDRASE INHIBITORS AND BETABLOCKERS
by: M. V. Protsenko
Published: (2015-03-01)

Comparative study to assess efficacy and safety of brinzolamide1% and timolol0.5% fixed combination eye drops versus dorzolamide2% and timolol0.5% fixed combination eye drops in management of open-angle glaucoma
by: Prerana Agarwal, et al.
Published: (2022-01-01)

PHARMACOECONOMIC STUDY OF PRIMARY OPEN-ANGLE GLAUCOMA TREATMENT WITH COMBINATIONS OF PROSTAGLANDIN ANALOGUES AND BETA-BLOCKERS
by: A. Yu. Kulikov, et al.
Published: (2015-03-01)

Efficacy of dorzolamide in improving ocular blood flow in patients with open-angle glaucoma: The Indian carbonic anhydrase inhibitor trial
by: Pratheeba D Nivean, et al.
Published: (2022-01-01)

Efficacy and tolerability of brinzolamide/brimonidine suspension and prostaglandin analogs in patients previously treated with dorzolamide/timolol solution and prostaglandin analogs
by: Lo JS, et al.
Published: (2016-03-01)

Impact of combination of local carbonic anhydrase inhibitors and beta-blockers on intraocular pressure, visual functions and eye hemodynamics in primary open-angle glaucoma
by: T. N. Malishevskaya, et al.
Published: (2021-06-01)

Quantification of Carbonic Anhydrase Inhibitors and Metabolites in Urine and Hair of Patients and Their Relatives
by: Alfredo Fabrizio Lo Faro, et al.
Published: (2022-09-01)

PRIMARY OPEN-ANGLE GLAUCOMA AND FARMACOECONOMICS - REVIEW
by: Sarenac Vulovic Tatjana, et al.
Published: (2016-12-01)

Efficiency and safety of the fixed latanoprost/ dorzolamide combination in open-angle glaucoma hypotensive treatment
by: V. V. Neroev, et al.
Published: (2023-10-01)

Comparison of the efficacy and safety of fixed combination travoprost/timolol and dorzolamide/timolol in patients with primary open-angle glaucoma and ocular hypertension
by: Babić Nikola, et al.
Published: (2013-01-01)

Brinzolamide/timolol versus dorzolamide/timolol fixed combinations: A hospital-based, prospective, randomized study
by: Mary S Galose, et al.
Published: (2016-01-01)

Papillomacular retinoschisis associated with glaucoma: Response to topical carbonic anhydrase inhibitor
by: Masatoshi Haruta, et al.
Published: (2020-09-01)

Adjunctive antihypertensive therapy of primary glaucoma with a fixed combination drug of 1% brinzolamide and 0.5% timolol: efficacy and safety
by: S. Yu. Petrov, et al.
Published: (2023-07-01)

Prostaglandin vs Dorzolamide/Timolol Effect on Anterior Scleral Thickness in Patients with Primary Open Angle Glaucoma By Using Anterior Segment Optical Coherence Tomography
by: Aya Mostafa Abozeid Makled *, et al.
Published: (2024-01-01)

Patient Flows, Patient Distribution Computations and Medicines Accounting in the Pharmacoeconomic Models Through Procurement Perspective
by: Yagudina R, et al.
Published: (2021-07-01)

Pharmacoeconomic analysis of Anti-inhibitor coagulant complex (AICC) in the treatment of inhibitor hemophilia
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Experience in Application of the Combinations Dorzolamide / Timolol and Brinzolamide / Timolol for the Prevention of Intraocular Hypertension in Patients with Silicone Oil Tamponade of the Vitreal Cavity
by: A. N. Kazennov, et al.
Published: (2024-10-01)

Comparison of the Intraocular Pressure-Lowering Efficacy and Safety of the Brinzolamide/Brimonidine Fixed-Dose Combination versus Concomitant Use of Brinzolamide and Brimonidine for Management of Open-Angle Glaucoma or Ocular Hypertension
by: Wang N, et al.
Published: (2020-01-01)

Acute serous and hemorrhagic choroidal effusion associated with topical dorzolamide therapy
by: Abdulla Shaheen, et al.
Published: (2023-09-01)

PHARMACOECONOMIC ANALYSIS OF DOCETAXEL IN THE ADJUVANT THERAPY OF BREAST CANCER
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Intraocular pressure-lowering effects of commonly used fixed combination drugs with timolol in the management of primary open angle glaucoma
by: Murat Atabey Ozer, et al.
Published: (2014-10-01)

RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research
by: V. V. Ryazhenov, et al.
Published: (2022-06-01)

Medical treatment of open-angle glaucoma
by: Mohammed M Abdull, et al.
Published: (2012-01-01)

Molecular characterization of a rare phenotype of X-linked retinoschisis with angle-closure glaucoma
by: Harathy Selvan, et al.
Published: (2019-01-01)

Pharmacoeconomic analysis of fluid therapy in the treatment of patients with peritonitis
by: R. I. Yagudina, et al.
Published: (2015-03-01)

Impact of dorzolamide, benzalkonium-preserved dorzolamide and benzalkonium-preserved brinzolamide on selected biomarkers of oxidative stress in the tear film
by: Lech Sedlak, et al.
Published: (2021-09-01)

Association between hypertriglyceridemia and open angle glaucoma: A case report
by: Mayuri Bakulesh Khamar, et al.
Published: (2019-01-01)

Pharmacoeconomics of chronic kidney disease
by: R. I. Yagudina, et al.
Published: (2018-02-01)

Recent overviews on the drug delivery aspects and applications of brinzolamide for the management of glaucoma
by: Yash Sharma, et al.
Published: (2023-03-01)

Risk of open angle glaucoma due to tumor necrosis factor alpha gene polymorphisms
by: Mona Abdel Hamid, et al.
Published: (2016-02-01)

Pharmacoeconomic Evaluation of Cancer Biosimilars Worldwide: A Systematic Review
by: Hui-Yao Huang, et al.
Published: (2020-11-01)

A comparative evaluation of the efficacy and safety of Latanoprost-Optic and Xalatan used as monotherapy and combined with Dorzolamide-Optic for primary open-angle glaucoma under clinical practice conditions
by: D. P. Novikov, et al.
Published: (2023-03-01)

Pattern Electroretinography in Glaucoma Suspects and Early Primary Open Angle Glaucoma
by: Ebrahim Jafarzadehpour, et al.
Published: (2013-01-01)

PHARMACOECONOMIC STUDY OVER USE OF ANTICHOLINERGIC BRONCHODILATORS (SPIRIVA AND ATROVENT) FOR TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
by: A. U. Kulikov, et al.
Published: (2015-03-01)

PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

Quality of life of patients with primary open-angle glaucoma, primary angle closure glaucoma, and pseudoexfoliation glaucoma in Central Serbia
by: Marčeta Elizabeta, et al.
Published: (2023-01-01)

Suicide risk in juvenile open angle glaucoma patients
by: Hye-Jeong Seong, et al.
Published: (2024-10-01)

Managing a patient with open-angle glaucoma: a case study
by: Mohammed M Abdull, et al.
Published: (2012-01-01)

EVALUATION OF DRUG THERAPY IN PROGRESSING DIFFERENTIATED THYROID CANCER REFRACTORY TO RADIOACTIVE IODINE IN PATIENTS RESIDING IN THE RUSSIAN FEDERATION : PHARMACOECONOMIC ASPECTS
by: M. Yu. Frolov, et al.
Published: (2017-05-01)

Levels of cytokines in the aqueous humor of eyes with primary open angle glaucoma, pseudoexfoliation glaucoma and cataract
by: Nervana Khalef, et al.
Published: (2017-02-01)